Ahmed, Y.M.; Abdelgawad, M.A.; Shalaby, K.; Ghoneim, M.M.; AboulMagd, A.M.; Abdelwahab, N.S.; Hassan, H.M.; Othman, A.M.
Pioglitazone Synthetic Analogue Ameliorates Streptozotocin-Induced Diabetes Mellitus through Modulation of ACE 2/Angiotensin 1–7 via PI3K/AKT/mTOR Signaling Pathway. Pharmaceuticals 2022, 15, 341.
https://doi.org/10.3390/ph15030341
AMA Style
Ahmed YM, Abdelgawad MA, Shalaby K, Ghoneim MM, AboulMagd AM, Abdelwahab NS, Hassan HM, Othman AM.
Pioglitazone Synthetic Analogue Ameliorates Streptozotocin-Induced Diabetes Mellitus through Modulation of ACE 2/Angiotensin 1–7 via PI3K/AKT/mTOR Signaling Pathway. Pharmaceuticals. 2022; 15(3):341.
https://doi.org/10.3390/ph15030341
Chicago/Turabian Style
Ahmed, Yasmin M., Mohamed A. Abdelgawad, Khaled Shalaby, Mohammed M. Ghoneim, Asmaa M. AboulMagd, Nada S. Abdelwahab, Hossam M. Hassan, and Asmaa M. Othman.
2022. "Pioglitazone Synthetic Analogue Ameliorates Streptozotocin-Induced Diabetes Mellitus through Modulation of ACE 2/Angiotensin 1–7 via PI3K/AKT/mTOR Signaling Pathway" Pharmaceuticals 15, no. 3: 341.
https://doi.org/10.3390/ph15030341
APA Style
Ahmed, Y. M., Abdelgawad, M. A., Shalaby, K., Ghoneim, M. M., AboulMagd, A. M., Abdelwahab, N. S., Hassan, H. M., & Othman, A. M.
(2022). Pioglitazone Synthetic Analogue Ameliorates Streptozotocin-Induced Diabetes Mellitus through Modulation of ACE 2/Angiotensin 1–7 via PI3K/AKT/mTOR Signaling Pathway. Pharmaceuticals, 15(3), 341.
https://doi.org/10.3390/ph15030341